Rohan Pisharody

Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism.

B. Ouyang, Jochen Reiser, N. Witek, 2022, Parkinsonism & related disorders.

EGF Treatment Improves Motor Behavior and Cortical GABAergic Function in the R6/2 Mouse Model of Huntington’s Disease

Kuei Yuan Tseng, S. Brady, G. Morfini, 2019, Molecular Neurobiology.

Epidermal growth factor treatment of female mice that express APOE4 at an age of advanced pathology mitigates behavioral and cerebrovascular dysfunction

S. Alford, K. Cai, Frederick C. Damen, 2020, Heliyon.